A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

Details for Australian Patent Application No. 2010253830 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Teschner, Wolfgang; Butterweck, Harald Arno; Pljevljakovic, Azra; Bauer, Theresa Friederike; Koelbl, Bernhard; Schwarz, Hans-Peter; Nikolic, Nebojsa; Polsler, Gerhard; Kindermann, Johanna

Agent Cullens

Pub. Number AU-A-2010253830

PCT Pub. Number WO2010/138736

Priority 61/181,606 27.05.09 US

Filing date 27 May 2010

Wipo publication date 2 December 2010

International Classifications

C07K 16/06 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - from serum

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/138736 Priority application(s): WO2010/138736

22 December 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Teschner, Wolfgang; Butterweck, Harald; Pljevljakovic, Azra; Bauer, Theresa Friederike; Koelbl, Bernhard; Schwarz, HansPeter; Nikolic, Nebojsa; Poelsler, Gerhard and Kindermann, Johanna

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010253834-Inhibition 0f inflammation using antagonists of MUC1

2010253827-Precision axle spindle and wheel end assembly for heavy-duty vehicles